Hyperactive Rac1 could therefore increase basal growth through its (TGF-β/Smad-independent) growth promoting effect and, at the same time, protect tumour cells, which have not yet accumulated inactivating mutations in the TGF-β pathway, from exaggerated growth restraints by TGF-β. Here, RAC1 is linked to neoplasm.